Safety and efficacy of bone marrow derived-mesenchymal stem cells transplantation in patients with amyotrophic lateral sclerosis
Author:
Publisher
Elsevier BV
Subject
Developmental Biology,Biomedical Engineering,Biomaterials
Reference43 articles.
1. Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis;Armon;Muscle Nerve,2000
2. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND);Miller;Amyotroph Lateral Scler Other Motor Neuron Disord,2003
3. July 2017 ENCALS statement on edaravone;Al-Chalabi;Amyotroph Lateral Scler Frontotemporal Degener,2017
4. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease;Wahid;Cochrane Database Syst Rev,2019
5. Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats;Zalfa;Cell Death Dis,2019
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A closer look at Mesenchymal Stem cells (MSCs), their potential and function as game-changers of Modern Medicine;Recent Update on Mesenchymal Stem Cells [Working Title];2023-12-07
2. Chromosomal Instability in Various Generations of Human Mesenchymal Stem Cells Following the Therapeutic Radiation;Stem Cells International;2023-08-29
3. Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives;IRAN J BASIC MED SCI;2023
4. Human Bone Marrow-Derived Mesenchymal Stem Cell Applications in Neurodegenerative Disease Treatment and Integrated Omics Analysis for Successful Stem Cell Therapy;Bioengineering;2023-05-22
5. Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study;Frontiers in Aging Neuroscience;2023-04-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3